Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Neurobiology of LRRK2 and its Role in the Pathogenesis of Parkinson’s Disease
Hardy J. Rideout, Leonidas Stefanis
Neurochemical Research (2013) Vol. 39, Iss. 3, pp. 576-592
Closed Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Colonic bacterial composition in Parkinson's disease
Ali Keshavarzian, Stefan J. Green, Phillip A. Engen, et al.
Movement Disorders (2015) Vol. 30, Iss. 10, pp. 1351-1360
Closed Access | Times Cited: 1102
Autophagy in Parkinson's Disease
Xu Hou, Jens O. Watzlawik, Fabienne C. Fiesel, et al.
Journal of Molecular Biology (2020) Vol. 432, Iss. 8, pp. 2651-2672
Open Access | Times Cited: 280
Solid-phase peptide synthesis: an overview focused on the preparation of biologically relevant peptides
José M. Palomo
RSC Advances (2014) Vol. 4, Iss. 62, pp. 32658-32672
Open Access | Times Cited: 229
LRRK2 levels in immune cells are increased in Parkinson’s disease
Darcie A. Cook, George T. Kannarkat, Amarallys F. Cintron, et al.
npj Parkinson s Disease (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 229
The role of the LRRK2 gene in Parkinsonism
Jieqiong Li, Lan Tan, Jin‐Tai Yu
Molecular Neurodegeneration (2014) Vol. 9, Iss. 1
Open Access | Times Cited: 223
Calcium Signaling Regulates Autophagy and Apoptosis
Pramod Sukumaran, Viviane Nascimento Da Conceicao, Yuyang Sun, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 2125-2125
Open Access | Times Cited: 165
Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders
David S. Goldstein, Irwin J. Kopin, Yehonatan Sharabi
Pharmacology & Therapeutics (2014) Vol. 144, Iss. 3, pp. 268-282
Open Access | Times Cited: 149
Crystal structure of the WD40 domain dimer of LRRK2
Pengfei Zhang, Ying Fan, Heng Ru, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 5, pp. 1579-1584
Open Access | Times Cited: 84
Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patients
Shani Stern, Shong Lau, Andreea Manole, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 38
An early endosome regulator, Rab5b, is an LRRK2 kinase substrate
Hye Jin Yun, Hye Jung Kim, Inhwa Ga, et al.
The Journal of Biochemistry (2015) Vol. 157, Iss. 6, pp. 485-495
Closed Access | Times Cited: 74
LRRK2 deficiency induced mitochondrial Ca2+ efflux inhibition can be rescued by Na+/Ca2+/Li+ exchanger upregulation
Marthe H. R. Ludtmann, Marko Kostić, Amy Horne, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 4
Open Access | Times Cited: 72
Splicing: is there an alternative contribution to Parkinson’s disease?
Valentina La Cognata, Velia D’Agata, Francesca Cavalcanti, et al.
Neurogenetics (2015) Vol. 16, Iss. 4, pp. 245-263
Open Access | Times Cited: 70
Chaperone mediated autophagy to the rescue: A new-fangled target for the treatment of neurodegenerative diseases
Maria Xilouri, Leonidas Stefanis
Molecular and Cellular Neuroscience (2015) Vol. 66, pp. 29-36
Closed Access | Times Cited: 60
Caenorhabditis elegans as a model system for studying aging-associated neurodegenerative diseases
Kate M. Van Pelt, Matthias C. Truttmann
Translational Medicine of Aging (2020) Vol. 4, pp. 60-72
Open Access | Times Cited: 43
Long-Term Outcomes of Genetic Parkinson’s Disease
Jan Aasly
Journal of Movement Disorders (2020) Vol. 13, Iss. 2, pp. 81-96
Open Access | Times Cited: 39
Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease
Albert Frank Magnusen, Shelby Loraine Hatton, Reena Rani, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 36
LRRK2 regulates retrograde synaptic compensation at the Drosophila neuromuscular junction
Jay Penney, Kazuya Tsurudome, Edward H. Liao, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 44
Vesicular Dysfunction and the Pathogenesis of Parkinson’s Disease: Clues From Genetic Studies
Kirsten Ebanks, Patrick A. Lewis, Rina Bandopadhyay
Frontiers in Neuroscience (2020) Vol. 13
Open Access | Times Cited: 33
Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's disease
Mai Mohamed Abdelmoaty, Jatin Machhi, Pravin Yeapuri, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 7
Open Access | Times Cited: 19
Exploring Parkinson-associated kinases for CRISPR/Cas9-based gene editing: beyond alpha-synuclein
Heba M. Mansour, Aiman S. El‐Khatib
Ageing Research Reviews (2023) Vol. 92, pp. 102114-102114
Closed Access | Times Cited: 11
Advances in autophagy for Parkinson’s disease pathogenesis and treatment
Xiaojie Zhang, Huan Zhang, Jie Dong, et al.
Ageing and Neurodegenerative Diseases (2025) Vol. 5, Iss. 1
Open Access
Alpha-Synuclein Pathophysiology in Neurodegenerative Disorders: A Review Focusing on Molecular Mechanisms and Treatment Advances in Parkinson’s Disease
Shakila Yaribash, Keyhan Mohammadi, Mahmood Alizadeh Sani
Cellular and Molecular Neurobiology (2025) Vol. 45, Iss. 1
Open Access
ERKed by LRRK2: A cell biological perspective on hereditary and sporadic Parkinson's disease
Manish Verma, Erin Steer, Charleen T. Chu
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2013) Vol. 1842, Iss. 8, pp. 1273-1281
Open Access | Times Cited: 37
Neuronal microtubules and proteins linked to Parkinson’s disease: a relevant interaction?
Alessandra Maria Calogero, Samanta Mazzetti, Gianni Pezzoli, et al.
Biological Chemistry (2019) Vol. 400, Iss. 9, pp. 1099-1112
Open Access | Times Cited: 31
Neuroprotective potential of Epigenetic modulators, its regulation and therapeutic approaches for the management of Parkinson's disease
Shobha Kumari, Sakshi Gupta, Rajesh Sukhija, et al.
European Journal of Pharmacology (2024) Vol. 985, pp. 177123-177123
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top